Protocol Ledger

NCT07711262 · Phase III · RECRUITING

Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis

Interventional Phase III clinical trial protocol NCT07711262 sponsored by Fujian Mindong Rejuvenation Pharmaceutical Co in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-18 Enrollment: 550 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07711262
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)550 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07711262
Protocol FieldVerified Registry Value
NCT IdentifierNCT07711262
Consolidated Lead SponsorFujian Mindong Rejuvenation Pharmaceutical Co
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment550 participants (ESTIMATED)
Registered Start Date2026-08-18
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI